Physician profile
Michelle J Smith
NPI 1225297070
$46,478.46
in general payments reported to CMS, 2019-2025
18 companies · $45K in 2025
The $45K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.56 · 2020: $180 · 2022: $140 · 2023: $207 · 2024: $580 · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Travel and Lodging: $7,048 · Food and Beverage: $2,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,675.00 |
| Travel and Lodging | $7,048.36 |
| Food and Beverage | $2,374.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $45,179.50 | 2023-2025 | Surpass Evolve, Neuroform Atlas, Tgs |
| Depuy Synthes Sales INC. | $459.14 | 2022-2024 | Embotrap |
| Philips North America LLC | $162.44 | 2020 | |
| Ceribell, INC. | $144.30 | 2025 | Pocket Eeg Device |
| Arcuro Medical INC | $137.57 | 2024 | Superball |
| Microvention, INC. | $96.59 | 2023-2025 | Eric Retrieval Device, Web Aneurysm Embolization System |
| Astrazeneca Pharmaceuticals LP | $48.55 | 2019-2024 | Lynparza, Enhertu |
| Sanofi Pasteur INC. | $37.48 | 2023 | |
| Route 92 Medical, INC. | $25.18 | 2025 | |
| Medtronic USA, INC. | $25.10 | 2019 | |
| Janssen Biotech, INC. | $24.47 | 2023 | Erleada |
| Shockwave Medical, INC | $23.69 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $22.74 | 2019 | |
| Pfizer INC. | $21.46 | 2024 | |
| Genmab U.S., INC. | $20.58 | 2024 | Tivdak |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.24 | 2020 | |
| Genentech USA, INC. | $17.12 | 2024 | Activase |
| Boston Scientific Corporation | $15.31 | 2023 | Ilab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.